New drug BBT002 aims to tackle COPD and chronic sinusitis in early trial

NCT ID NCT06944925

First seen Jul 01, 2026 · Last updated Jul 01, 2026

Summary

This study tests a new drug, BBT002, in healthy volunteers and people with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP). The trial is double-blind and placebo-controlled, meaning some participants get the drug and some get a dummy treatment. The main goal is to check safety and how the body handles the drug, with a secondary look at whether it helps symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BBT002

What this could lead to

If successful, BBT002 could become a new treatment option for people with COPD or chronic sinusitis with nasal polyps.

What could go wrong

This is an early phase 1 trial, so the main goal is safety, not effectiveness. The drug may not work or could have side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aleksandre Aladashvili Clinic LLC

    RECRUITING

    Tbilisi, 0198, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Centrum Nowoczesnych Terapii Dobry Lekarz Sp. z o.o.

    NOT_YET_RECRUITING

    Krakow, 31-011, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Equity Medical - Owensboro

    NOT_YET_RECRUITING

    Owensboro, Kentucky, 42303, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Equity Medical Bowling Green

    RECRUITING

    Bowling Green, Kentucky, 42104, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Equity Medical LLC

    RECRUITING

    New York, New York, 10023, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Geo Hospitals Tbilisi Multiprofile Medical Center

    RECRUITING

    Tbilisi, 0198, Georgia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • LEPL The First University Clinic of Tbilisi State Medical University

    RECRUITING

    Tbilisi, 0198, Georgia

    Contact Email: •••••@•••••

    Contact

  • Linear Clinical Research

    RECRUITING

    Perth, Western Australia, 6009, Australia

    Contact

    Contact

  • Ltd Aversi Clinic

    RECRUITING

    Tbilisi, 0198, Georgia

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Clinical Research

    RECRUITING

    Brisbane, 4068, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Momentum Clinical Research

    RECRUITING

    Pukekohe, 2120, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Momentum Clinical Research

    RECRUITING

    Wellington, 6021, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Momentum Clinical Research Hamilton

    NOT_YET_RECRUITING

    Rotorua, Hamilton, 3010, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Uniwersyteckie Centrum Kliniczne Osrodka Badan Klinicznych Wczesnych Faz

    NOT_YET_RECRUITING

    Gdansk, 80-214, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact